About SONIRE Therapeutics
SONIRE Therapeutics is a company based in Tokyo (Japan) founded in 2020.. SONIRE Therapeutics has raised $16.97 million across 2 funding rounds from investors including JA Mitsui Leasing, Carbon Ventures and Resona Capital. SONIRE Therapeutics operates in a competitive market with competitors including Insightec, HistoSonics, Profound Medical, Theraclion and Carthera, among others.
- Headquarter Tokyo, Japan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.97 M (USD)
in 2 rounds
-
Latest Funding Round
$16.97 M (USD), Series B
Nov 30, 2022
-
Investors
JA Mitsui Leasing
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SONIRE Therapeutics
SONIRE Therapeutics has successfully raised a total of $16.97M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $16.97 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $17.0M
- First Round First Round
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series B - SONIRE Therapeutics | Valuation |
investors |
|
| Jun, 2021 | Amount | Series A - SONIRE Therapeutics | Valuation | Fast Track Initiative |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SONIRE Therapeutics
SONIRE Therapeutics has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include JA Mitsui Leasing, Carbon Ventures and Resona Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Carbon Ventures is focused on investing in sustainable infrastructure technologies.
|
Founded Year | Domain | Location | |
|
Venture capital services are provided to support startups and innovation.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in biotech, adtech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SONIRE Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SONIRE Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sonire Therapeutics Comparisons
Competitors of SONIRE Therapeutics
SONIRE Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, HistoSonics, Profound Medical, Theraclion and Carthera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
|
|
| domain | founded_year | HQ Location |
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
|
|
| domain | founded_year | HQ Location |
Image-guided prostate ablation systems for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Provider of non-invasive robotic ultrasound therapy devices
|
|
| domain | founded_year | HQ Location |
Ultrasound-based medical devices for brain tumor treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sonire Therapeutics
Frequently Asked Questions about SONIRE Therapeutics
When was SONIRE Therapeutics founded?
SONIRE Therapeutics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is SONIRE Therapeutics located?
SONIRE Therapeutics is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Who is the current CEO of SONIRE Therapeutics?
Tohru Satoh is the current CEO of SONIRE Therapeutics.
Is SONIRE Therapeutics a funded company?
SONIRE Therapeutics is a funded company, having raised a total of $16.97M across 2 funding rounds to date.
What does SONIRE Therapeutics do?
SONIRE Therapeutics was founded in 2020 in Tokyo, Japan, within the medical device sector. High-intensity focused ultrasound treatment systems are developed by the company, utilizing cavitation bubbles to improve efficacy and enable visualization through heating mechanisms. Pancreatic cancer is addressed via clinical trials that employ high-energy ultrasound waves to target and destroy cancer cells in specific areas. Operations focus on advancing non-invasive therapeutic technologies for oncology applications.
Who are the top competitors of SONIRE Therapeutics?
SONIRE Therapeutics's top competitors include Insightec, HistoSonics and Profound Medical.
Who are SONIRE Therapeutics's investors?
SONIRE Therapeutics has 13 investors. Key investors include JA Mitsui Leasing, Carbon Ventures, Resona Capital, Daiwa Corporate Investment, and Nissay Capital.